Skin neurogenic inflammation

Seminars in Immunopathology

Volumn 40, Issue 3, 2018, Pages 249-259

  Choi, Jae Eun ^a   Di Nardo, Anna ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APREPITANT; BOTULINUM TOXIN A; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCITONIN GENE RELATED PEPTIDE; EMEND; G PROTEIN COUPLED RECEPTOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; MRGPR PROTEIN; NERVE GROWTH FACTOR; NEUROPEPTIDE; PROTEINASE ACTIVATED RECEPTOR; TRANSIENT RECEPTOR POTENTIAL CHANNEL; UNCLASSIFIED DRUG;

ATOPIC DERMATITIS; CELL INTERACTION; CYTOKINE RELEASE; DERMATITIS; HUMAN; IMMUNOMODULATION; MAST CELL; NEURODERMATITIS; NEUROGENIC INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REVIEW; ROSACEA; SENSORY NERVE; SKIN CELL; SKIN NERVE; SKIN NEUROGENIC INFLAMMATION; ANIMAL; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; SKIN; SKIN DISEASE;

ANIMALS; HUMANS; NEUROGENIC INFLAMMATION; NEUROPEPTIDES; SKIN; SKIN DISEASES;

EID: 85047241633     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-018-0675-z     Document Type: Review

References (148)

1. Huynh M, Gupta R, Koo JY (2013) Emotional stress as a trigger for inflammatory skin disorders. Semin Cutan Med Surg 32(2):68–72
2. Chen Y, Lyga J (2014) Brain-skin connection: stress, inflammation and skin aging. Inflamm Allergy Drug Targets 13(3):177–190
3. Stricker (1876) Mikroskopische Studien iiber Wachstum und Wechsel der Haai'e,. In: Ebner V (ed) manual of human embriology, vol xxiv. Sitz. Her. d. K. Akad. d. Wiss., Wien.
4. Bayliss WM, Starling EH (1901) The movements and innervation of the small intestine. J Physiol 26(3–4):125–138. 10.1113/jphysiol.1901.sp000827
5. Peters EM (2012) The neuroendocrine-immune connection regulates chronic inflammatory disease in allergy. Chem Immunol Allergy 98:240–252. 10.1159/000336527
6. Chiu IM, von Hehn CA, Woolf CJ (2012) Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology. Nat Neurosci 15(8):1063–1067. 10.1038/nn.3144
7. Szolcsanyi J (1996) Capsaicin-sensitive sensory nerve terminals with local and systemic efferent functions: facts and scopes of an unorthodox neuroregulatory mechanism. Prog Brain Res 113:343–359
8. Liezmann C, Klapp B, Peters EM (2011) Stress, atopy and allergy: a re-evaluation from a psychoneuroimmunologic persepective. Derm Endocrinol 3(1):37–40. 10.4161/derm.3.1.14618
9. Peters EM, Ericson ME, Hosoi J, Seiffert K, Hordinsky MK, Ansel JC, Paus R, Scholzen TE (2006) Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance. J Investig Dermatol 126(9):1937–1947. 10.1038/sj.jid.5700429
10. Botchkarev VA, Yaar M, Peters EM, Raychaudhuri SP, Botchkareva NV, Marconi A, Raychaudhuri SK, Paus R, Pincelli C (2006) Neurotrophins in skin biology and pathology. J Investig Dermatol 126(8):1719–1727. 10.1038/sj.jid.5700270
11. Roosterman D, Goerge T, Schneider SW, Bunnett NW, Steinhoff M (2006) Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol Rev 86(4):1309–1379. 10.1152/physrev.00026.2005
12. Cevikbas F, Steinhoff A, Homey B, Steinhoff M (2007) Neuroimmune interactions in allergic skin diseases. Curr Opin Allergy Clin Immunol 7(5):365–373. 10.1097/ACI.0b013e3282a644d2
13. Park YM, Kim CW The effects of substance P and vasoactive intestinal peptide on interleukin-6 synthesis in cultured human keratinocytes. J Dermatol Sci 22(1):17–23. https://doi.org/10.1016/S0923-1811(99)00038-9
14. Song IS, Bunnett NW, Olerud JE, Harten B, Steinhoff M, Brown JR, Sung KJ, Armstrong CA, Ansel JC (2000) Substance P induction of murine keratinocyte PAM 212 interleukin 1 production is mediated by the neurokinin 2 receptor (NK-2R). Exp Dermatol 9(1):42–52
15. Burbach GJ, Kim KH, Zivony AS, Kim A, Aranda J, Wright S, Naik SM, Caughman SW, Ansel JC, Armstrong CA The neurosensory tachykinins substance P and neurokinin A directly induce keratinocyte nerve growth factor. J Investig Dermatol 117(5):1075–1082. 10.1046/j.0022-202x.2001.01498.x
16. Dallos A, Kiss M, Polyánka H, Dobozy A, Kemény L, Husz S Effects of the neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytes. Neuropeptides 40(4):251–263. 10.1016/j.npep.2006.06.002
17. Nakano Y (2004) Stress-induced modulation of skin immune function: two types of antigen-presenting cells in the epidermis are differentially regulated by chronic stress. Br J Dermatol 151(1):50–64. 10.1111/j.1365-2133.2004.05980.x
18. Beresford L, Orange O, Bell EB, Miyan JA (2004) Nerve fibres are required to evoke a contact sensitivity response in mice. Immunology 111(1):118–125
19. Joachim RA, Handjiski B, Blois SM, Hagen E, Paus R, Arck PC Stress-induced neurogenic inflammation in murine skin skews dendritic cells towards maturation and migration. Am J Pathol 173(5):1379–1388. 10.2353/ajpath.2008.080105
20. Rosa AC, Fantozzi R (2013) The role of histamine in neurogenic inflammation. Br J Pharmacol 170(1):38–45. 10.1111/bph.12266
21. Liu JY, Hu JH, Zhu QG, Li FQ, Sun HJ (2006) Substance P receptor expression in human skin keratinocytes and fibroblasts. Br J Dermatol 155(4):657–662. 10.1111/j.1365-2133.2006.07408.x
22. Bae SJ, Matsunaga Y, Takenaka M, Tanaka Y, Hamazaki Y, Shimizu K, Katayama I (2002) Substance P induced preprotachykinin-a mRNA, neutral endopeptidase mRNA and substance P in cultured normal fibroblasts. Int Arch Allergy Immunol 127(4):316–321 57749
23. Brain SD, Williams TJ (1989) Interactions between the tachykinins and calcitonin gene-related peptide lead to the modulation of oedema formation and blood flow in rat skin. Br J Pharmacol 97(1):77–82
24. Saria A (1984) Substance P in sensory nerve fibres contributes to the development of oedema in the rat hind paw after thermal injury. Br J Pharmacol 82(1):217–222
25. Lindsey KQ, Caughman SW, Olerud JE, Bunnett NW, Armstrong CA, Ansel JC (2000) Neural regulation of endothelial cell-mediated inflammation. J Investig Dermatol Symp Proc 5(1):74–78. 10.1046/j.1087-0024.2000.00013.x
26. Castellani ML, Galzio RJ, Felaco P, Tripodi D, Toniato E, De Lutiis MA, Conti F, Fulcheri M, Conti C, Theoharides TC, Caraffa A, Antinolfi P, Felaco M, Tete S, Pandolfi F, Shaik-Dasthagirisaheb YB (2010) VEGF, substance P and stress, new aspects: a revisited study. J Biol Regul Homeost Agents 24(3):229–237
27. Kohara H, Tajima S, Yamamoto M, Tabata Y (2010) Angiogenesis induced by controlled release of neuropeptide substance P. Biomaterials 31(33):8617–8625. 10.1016/j.biomaterials.2010.07.079
28. Mishima T, Ito Y, Hosono K, Tamura Y, Uchida Y, Hirata M, Suzsuki T, Amano H, Kato S, Kurihara Y, Kurihara H, Hayashi I, Watanabe M, Majima M (2011) Calcitonin gene-related peptide facilitates revascularization during hindlimb ischemia in mice. Am J Phys Heart Circ Phys 300(2):H431–H439. 10.1152/ajpheart.00466.2010
29. Zhou Z, Hu CP, Wang CJ, Li TT, Peng J, Li YJ (2010) Calcitonin gene-related peptide inhibits angiotensin II-induced endothelial progenitor cells senescence through up-regulation of klotho expression. Atherosclerosis 213(1):92–101. 10.1016/j.atherosclerosis.2010.08.050
30. Ding W, Stohl LL, Wagner JA, Granstein RD (2008) Calcitonin gene-related peptide biases Langerhans cells toward Th2-type immunity. J Immunol (Baltimore, Md: 1950) 181(9):6020–6026
31. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393(6683):333–339. 10.1038/30666
32. Garret C, Carruette A, Fardin V, Moussaoui S, Peyronel JF, Blanchard JC, Laduron PM (1991) Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Proc Natl Acad Sci U S A 88(22):10208–10212
33. Stander S, Siepmann D, Herrgott I, Sunderkotter C, Luger TA (2010) Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy. PLoS One 5(6):e10968. 10.1371/journal.pone.0010968
34. Wrobel Goldberg S, Silberstein SD (2015) Targeting CGRP: a new era for migraine treatment. CNS drugs 29(6):443–452. 10.1007/s40263-015-0253-z
35. Ding W, Manni M, Stohl LL, Zhou XK, Wagner JA, Granstein RD (2012) Pituitary adenylate cyclase-activating peptide and vasoactive intestinal polypeptide bias Langerhans cell Ag presentation toward Th17 cells. Eur J Immunol 42(4):901–911. 10.1002/eji.201141958
36. Jans R, Sartor M, Jadot M, Poumay Y (2004) Calcium entry into keratinocytes induces exocytosis of lysosomes. Arch Dermatol Res 296(1):30–41. 10.1007/s00403-004-0469-0
37. Zhao P, Metcalf M, Bunnett NW (2014) Biased signaling of protease-activated receptors. Front Endocrinol 5:67. 10.3389/fendo.2014.00067
38. Chen Y, Yang C, Wang ZJ (2011) Proteinase-activated receptor 2 sensitizes transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential ankyrin 1 in paclitaxel-induced neuropathic pain. Neuroscience 193:440–451. 10.1016/j.neuroscience.2011.06.085
39. Steinhoff M, Neisius U, Ikoma A, Fartasch M, Heyer G, Skov PS, Luger TA, Schmelz M (2003) Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci Off J Soc Neurosci 23(15):6176–6180
40. Fu Q, Cheng J, Gao Y, Zhang Y, Chen X, Xie J (2015) Protease-activated receptor 4: a critical participator in inflammatory response. Inflammation 38(2):886–895. 10.1007/s10753-014-9999-6
41. Cocks TM, Moffatt JD (2000) Protease-activated receptors: sentries for inflammation? Trends Pharmacol Sci 21(3):103–108
42. Gouin O, Lebonvallet N, L'Herondelle K, Le Gall-Ianotto C, Buhe V, Plee-Gautier E, Carre JL, Lefeuvre L, Misery L (2015) Self-maintenance of neurogenic inflammation contributes to a vicious cycle in skin. Exp Dermatol 24(10):723–726. 10.1111/exd.12798
43. Mollanazar NK, Smith PK, Yosipovitch G (2016) Mediators of chronic pruritus in atopic dermatitis: getting the itch out? Clin Rev Allergy Immunol 51(3):263–292. 10.1007/s12016-015-8488-5
44. Briot A, Deraison C, Lacroix M, Bonnart C, Robin A, Besson C, Dubus P, Hovnanian A (2009) Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J Exp Med 206(5):1135–1147. 10.1084/jem.20082242
45. Tourdot BE, Conaway S, Niisuke K, Edelstein LC, Bray PF, Holinstat M (2014) Mechanism of race-dependent platelet activation through the protease-activated receptor-4 and Gq signaling axis. Arterioscler Thromb Vasc Biol 34(12):2644–2650. 10.1161/atvbaha.114.304249
46. Vellani V, Kinsey AM, Prandini M, Hechtfischer SC, Reeh P, Magherini PC, Giacomoni C, McNaughton PA (2010) Protease activated receptors 1 and 4 sensitize TRPV1 in nociceptive neurones. Mol Pain 6:61. 10.1186/1744-8069-6-61
47. Karanjia R, Spreadbury I, Bautista-Cruz F, Tsang ME, Vanner S (2009) Activation of protease-activated receptor-4 inhibits the intrinsic excitability of colonic dorsal root ganglia neurons. Neurogastroenterol Motil 21(11):1218–1221. 10.1111/j.1365-2982.2009.01353.x
48. Asfaha S, Cenac N, Houle S, Altier C, Papez MD, Nguyen C, Steinhoff M, Chapman K, Zamponi GW, Vergnolle N (2007) Protease-activated receptor-4: a novel mechanism of inflammatory pain modulation. Br J Pharmacol 150(2):176–185. 10.1038/sj.bjp.0706975
49. Houle S, Papez MD, Ferazzini M, Hollenberg MD, Vergnolle N (2005) Neutrophils and the kallikrein-kinin system in proteinase-activated receptor 4-mediated inflammation in rodents. Br J Pharmacol 146(5):670–678. 10.1038/sj.bjp.0706371
50. Liu Q, Tang Z, Surdenikova L, Kim S, Patel KN, Kim A, Ru F, Guan Y, Weng HJ, Geng Y, Undem BJ, Kollarik M, Chen ZF, Anderson DJ, Dong X (2009) Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus. Cell 139(7):1353–1365. 10.1016/j.cell.2009.11.034
51. Wilson SR, Gerhold KA, Bifolck-Fisher A, Liu Q, Patel KN, Dong X, Bautista DM (2011) TRPA1 is required for histamine-independent, Mas-related G protein-coupled receptor-mediated itch. Nat Neurosci 14(5):595–602. 10.1038/nn.2789
52. Solinski HJ, Gudermann T, Breit A (2014) Pharmacology and signaling of MAS-related G protein-coupled receptors. Pharmacol Rev 66(3):570–597. 10.1124/pr.113.008425
53. Bader M, Alenina N, Andrade-Navarro MA, Santos RA (2014) MAS and its related G protein-coupled receptors, Mrgprs. Pharmacol Rev 66(4):1080–1105. 10.1124/pr.113.008136
54. Solinski HJ, Petermann F, Rothe K, Boekhoff I, Gudermann T, Breit A (2013) Human Mas-related G protein-coupled receptors-X1 induce chemokine receptor 2 expression in rat dorsal root ganglia neurons and release of chemokine ligand 2 from the human LAD-2 mast cell line. PLoS One 8(3):e58756. 10.1371/journal.pone.0058756
55. Boillat A, Alijevic O, Kellenberger S (2014) Calcium entry via TRPV1 but not ASICs induces neuropeptide release from sensory neurons. Mol Cell Neurosci 61:13–22. 10.1016/j.mcn.2014.04.007
56. Stander S, Moormann C, Schumacher M, Buddenkotte J, Artuc M, Shpacovitch V, Brzoska T, Lippert U, Henz BM, Luger TA, Metze D, Steinhoff M (2004) Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures. Exp Dermatol 13(3):129–139. 10.1111/j.0906-6705.2004.0178.x
57. Story GM, Peier AM, Reeve AJ, Eid SR, Mosbacher J, Hricik TR, Earley TJ, Hergarden AC, Andersson DA, Hwang SW, McIntyre P, Jegla T, Bevan S, Patapoutian A (2003) ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 112(6):819–829
58. Hojland CR, Andersen HH, Poulsen JN, Arendt-Nielsen L, Gazerani P (2015) A human surrogate model of itch utilizing the TRPA1 agonist trans-cinnamaldehyde. Acta Derm Venereol 95(7):798–803. 10.2340/00015555-2103
59. Liang J, Ji Q, Ji W (2011) Role of transient receptor potential ankyrin subfamily member 1 in pruritus induced by endothelin-1. Neurosci Lett 492(3):175–178. 10.1016/j.neulet.2011.02.009
60. Liu T, Xu ZZ, Park CK, Berta T, Ji RR (2010) Toll-like receptor 7 mediates pruritus. Nat Neurosci 13(12):1460–1462. 10.1038/nn.2683
61. Kim SJ, Park GH, Kim D, Lee J, Min H, Wall E, Lee CJ, Simon MI, Lee SJ, Han SK (2011) Analysis of cellular and behavioral responses to imiquimod reveals a unique itch pathway in transient receptor potential vanilloid 1 (TRPV1)-expressing neurons. Proc Natl Acad Sci U S A 108(8):3371–3376. 10.1073/pnas.1019755108
62. Yun JW, Seo JA, Jeong YS, Bae IH, Jang WH, Lee J, Kim SY, Shin SS, Woo BY, Lee KW, Lim KM, Park YH (2011) TRPV1 antagonist can suppress the atopic dermatitis-like symptoms by accelerating skin barrier recovery. J Dermatol Sci 62(1):8–15. 10.1016/j.jdermsci.2010.10.014
63. Dai Y, Wang S, Tominaga M, Yamamoto S, Fukuoka T, Higashi T, Kobayashi K, Obata K, Yamanaka H, Noguchi K (2007) Sensitization of TRPA1 by PAR2 contributes to the sensation of inflammatory pain. J Clin Invest 117(7):1979–1987. 10.1172/jci30951
64. Malin S, Molliver D, Christianson JA, Schwartz ES, Cornuet P, Albers KM, Davis BM (2011) TRPV1 and TRPA1 function and modulation are target tissue dependent. J Neurosci 31(29):10516–10528. 10.1523/jneurosci.2992-10.2011
65. Wang S, Dai Y, Fukuoka T, Yamanaka H, Kobayashi K, Obata K, Cui X, Tominaga M, Noguchi K (2008) Phospholipase C and protein kinase A mediate bradykinin sensitization of TRPA1: a molecular mechanism of inflammatory pain. Brain 131(5):1241–1251. 10.1093/brain/awn060
66. Wilson SR, The L, Batia LM, Beattie K, Katibah GE, McClain SP, Pellegrino M, Estandian DM, Bautista DM (2013) The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell 155(2):285–295. 10.1016/j.cell.2013.08.057
67. Oh MH, Oh SY, Lu J, Lou H, Myers AC, Zhu Z, Zheng T (2013) TRPA1-dependent pruritus in IL-13-induced chronic atopic dermatitis. J Immunol (Baltimore, Md: 1950) 191(11):5371–5382. 10.4049/jimmunol.1300300
68. Bautista DM, Pellegrino M, Tsunozaki M (2013) TRPA1: a gatekeeper for inflammation. Annu Rev Physiol 75:181–200. 10.1146/annurev-physiol-030212-183811
69. Gouin O, L'Herondelle K, Lebonvallet N, Le Gall-Ianotto C, Sakka M, Buhe V, Plee-Gautier E, Carre JL, Lefeuvre L, Misery L, Le Garrec R (2017) TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: pro-inflammatory response induced by their activation and their sensitization. Protein Cell. 10.1007/s13238-017-0395-5
70. Kodji X, Aubdool AA, Brain SD (2016) Evidence for physiological and pathological roles for sensory nerves in the microvasculature and skin. Curr Res Transl Med 64(4):195–201. 10.1016/j.retram.2016.09.002
71. Two AM, Wu W, Gallo RL, Hata TR (2015) Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol 72(5):749–758; quiz 759-760. 10.1016/j.jaad.2014.08.028
72. Guzman-Sanchez DA, Ishiuji Y, Patel T, Fountain J, Chan YH, Yosipovitch G (2007) Enhanced skin blood flow and sensitivity to noxious heat stimuli in papulopustular rosacea. J Am Acad Dermatol 57(5):800–805. 10.1016/j.jaad.2007.06.009
73. Schwab VD, Sulk M, Seeliger S, Nowak P, Aubert J, Mess C, Rivier M, Carlavan I, Rossio P, Metze D, Buddenkotte J, Cevikbas F, Voegel JJ, Steinhoff M (2011) Neurovascular and neuroimmune aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc 15(1):53–62. 10.1038/jidsymp.2011.6
74. Sulk M, Seeliger S, Aubert J, Schwab VD, Cevikbas F, Rivier M, Nowak P, Voegel JJ, Buddenkotte J, Steinhoff M (2012) Distribution and expression of non-neuronal transient receptor potential (TRPV) ion channels in rosacea. J Investig Dermatol 132(4):1253–1262. 10.1038/jid.2011.424
75. Gerber PA, Buhren BA, Steinhoff M, Homey B (2011) Rosacea: the cytokine and chemokine network. J Investig Dermatol Symp Proc 15(1):40–47. 10.1038/jidsymp.2011.9
76. Ni Raghallaigh S, Powell FC (2014) Epidermal hydration levels in patients with rosacea improve after minocycline therapy. Br J Dermatol 171(2):259–266. 10.1111/bjd.12770
77. Hachem JP, Houben E, Crumrine D, Man MQ, Schurer N, Roelandt T, Choi EH, Uchida Y, Brown BE, Feingold KR, Elias PM (2006) Serine protease signaling of epidermal permeability barrier homeostasis. J Investig Dermatol 126(9):2074–2086. 10.1038/sj.jid.5700351
78. Spoendlin J, Voegel JJ, Jick SS, Meier CR (2013) Risk of rosacea in patients with diabetes using insulin or oral antidiabetic drugs. J Investig Dermatol 133(12):2790–2793. 10.1038/jid.2013.225
79. Pozsgai G, Bodkin JV, Graepel R, Bevan S, Andersson DA, Brain SD (2010) Evidence for the pathophysiological relevance of TRPA1 receptors in the cardiovascular system in vivo. Cardiovasc Res 87(4):760–768. 10.1093/cvr/cvq118
80. Graepel R, Fernandes ES, Aubdool AA, Andersson DA, Bevan S, Brain SD (2011) 4-oxo-2-nonenal (4-ONE): evidence of transient receptor potential ankyrin 1-dependent and -independent nociceptive and vasoactive responses in vivo. J Pharmacol Exp Ther 337(1):117–124. 10.1124/jpet.110.172403
81. Baylie RL, Brayden JE (2011) TRPV channels and vascular function. Acta Physiol (Oxford, England) 203(1):99–116. 10.1111/j.1748-1716.2010.02217.x
82. Helfrich YR, Maier LE, Cui Y, Fisher GJ, Chubb H, Fligiel S, Sachs D, Varani J, Voorhees J (2015) Clinical, histologic, and molecular analysis of differences between erythematotelangiectatic rosacea and telangiectatic photoaging. JAMA Dermatol 151(8):825–836. 10.1001/jamadermatol.2014.4728
83. Greeno EW, Mantyh P, Vercellotti GM, Moldow CF (1993) Functional neurokinin 1 receptors for substance P are expressed by human vascular endothelium. J Exp Med 177(5):1269–1276
84. Seeliger S, Buddenkotte J, Schmidt-Choudhury A, Rosignoli C, Shpacovitch V, von Arnim U, Metze D, Rukwied R, Schmelz M, Paus R, Voegel JJ, Schmidt WE, Steinhoff M (2010) Pituitary adenylate cyclase activating polypeptide: an important vascular regulator in human skin in vivo. Am J Pathol 177(5):2563–2575. 10.2353/ajpath.2010.090941
85. Muto Y, Wang Z, Vanderberghe M, Two A, Gallo RL, Di Nardo A (2014) Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea. J Investig Dermatol 134(11):2728–2736. 10.1038/jid.2014.222
86. Madva EN, Granstein RD (2013) Nerve-derived transmitters including peptides influence cutaneous immunology. Brain Behav Immun 34:1–10. 10.1016/j.bbi.2013.03.006
87. Shi X, Wang L, Li X, Sahbaie P, Kingery WS, Clark JD (2011) Neuropeptides contribute to peripheral nociceptive sensitization by regulating interleukin-1beta production in keratinocytes. Anesth Analg 113(1):175–183. 10.1213/ANE.0b013e31821a0258
88. Park KY, Hyun MY, Jeong SY, Kim BJ, Kim MN, Hong CK (2015) Botulinum toxin for the treatment of refractory erythema and flushing of rosacea. Dermatology (Basel, Switzerland) 230(4):299–301. 10.1159/000368773
89. Michalek IM, Loring B, John SM (2017) A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol JEADV 31(2):205–212. 10.1111/jdv.13854
90. Di Cesare A, Di Meglio P, Nestle FO (2009) The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Investig Dermatol 129(6):1339–1350. 10.1038/jid.2009.59
91. Veale D, Farrell M, Fitzgerald O (1993) Mechanism of joint sparing in a patient with unilateral psoriatic arthritis and a longstanding hemiplegia. Br J Rheumatol 32(5):413–416
92. Sowell JK, Pippenger MA, Crowe MJ (1993) Psoriasis contralateral to hemiparesis following cerebrovascular accident. Int J Dermatol 32(8):598–599
93. Sethi S, Sequeira W (1990) Sparing effect of hemiplegia on scleroderma. Ann Rheum Dis 49(12):999–1000
94. Joseph T, Kurian J, Warwick DJ, Friedmann PS (2005) Unilateral remission of psoriasis following traumatic nerve palsy. Br J Dermatol 152(1):185–186. 10.1111/j.1365-2133.2005.06330.x
95. Farber EM, Lanigan SW, Boer J (1990) The role of cutaneous sensory nerves in the maintenance of psoriasis. Int J Dermatol 29(6):418–420
96. Raychaudhuri SP, Farber EM (1993) Are sensory nerves essential for the development of psoriatic lesions? J Am Acad Dermatol 28(3):488–489
97. Dewing SB (1971) Remission of psoriasis associated with cutaneous nerve section. Arch Dermatol 104(2):220–221
98. Reyter I, Woodley D (2004) Widespread unilateral plaques in a 68-year-old woman after neurosurgery. Arch Dermatol 140(12):1531–1536. 10.1001/archderm.140.12.1531-e
99. Chowdhury MM, Hedges R, Lanigan SW (2000) Unilateral resolution of palmar eczema and hyperhidrosis complicated by Horner's syndrome following ipsilateral endoscopic cervical sympathectomy. Br J Dermatol 143(3):653–654
100. Ostrowski SM, Belkadi A, Loyd CM, Diaconu D, Ward NL (2011) Cutaneous denervation of psoriasiform mouse skin improves acanthosis and inflammation in a sensory neuropeptide-dependent manner. J Investig Dermatol 131(7):1530–1538. 10.1038/jid.2011.60
101. Saraceno R, Kleyn CE, Terenghi G, Griffiths CE (2006) The role of neuropeptides in psoriasis. Br J Dermatol 155(5):876–882. 10.1111/j.1365-2133.2006.07518.x
102. Payan DG, Brewster DR, Goetzl EJ (1983) Specific stimulation of human T lymphocytes by substance P. J Immunol (Baltimore, Md: 1950) 131(4):1613–1615
103. Maggi CA (1997) The effects of tachykinins on inflammatory and immune cells. Regul Pept 70(2–3):75–90
104. O'Halloran DJ, Bloom SR (1991) Calcitonin gene related peptide. BMJ (Clinical research ed) 302(6779):739–740
105. Kakurai M, Fujita N, Murata S, Furukawa Y, Demitsu T, Nakagawa H (2001) Vasoactive intestinal peptide regulates its receptor expression and functions of human keratinocytes via type I vasoactive intestinal peptide receptors. J Investig Dermatol 116(5):743–749. 10.1046/j.0022-202x.2001.doc.x
106. Amatya B, Wennersten G, Nordlind K (2008) Patients’ perspective of pruritus in chronic plaque psoriasis: a questionnaire-based study. J Eur Acad Dermatol Venereol JEADV 22(7):822–826. 10.1111/j.1468-3083.2008.02591.x
107. Amatya B, El-Nour H, Holst M, Theodorsson E, Nordlind K (2011) Expression of tachykinins and their receptors in plaque psoriasis with pruritus. Br J Dermatol 164(5):1023–1029. 10.1111/j.1365-2133.2011.10241.x
108. Chang SE, Han SS, Jung HJ, Choi JH (2007) Neuropeptides and their receptors in psoriatic skin in relation to pruritus. Br J Dermatol 156(6):1272–1277. 10.1111/j.1365-2133.2007.07935.x
109. Nakamura M, Toyoda M, Morohashi M (2003) Pruritogenic mediators in psoriasis vulgaris: comparative evaluation of itch-associated cutaneous factors. Br J Dermatol 149(4):718–730
110. Raychaudhuri SK, Raychaudhuri SP, Weltman H, Farber EM (2001) Effect of nerve growth factor on endothelial cell biology: proliferation and adherence molecule expression on human dermal microvascular endothelial cells. Arch Dermatol Res 293(6):291–295
111. Bischoff SC, Dahinden CA (1992) Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood 79(10):2662–2669
112. Taneda K, Tominaga M, Negi O, Tengara S, Kamo A, Ogawa H, Takamori K (2011) Evaluation of epidermal nerve density and opioid receptor levels in psoriatic itch. Br J Dermatol 165(2):277–284. 10.1111/j.1365-2133.2011.10347.x
113. Kou K, Nakamura F, Aihara M, Chen H, Seto K, Komori-Yamaguchi J, Kambara T, Nagashima Y, Goshima Y, Ikezawa Z (2012) Decreased expression of semaphorin-3A, a neurite-collapsing factor, is associated with itch in psoriatic skin. Acta Derm Venereol 92(5):521–528. 10.2340/00015555-1350
114. Zanchi M, Favot F, Bizzarini M, Piai M, Donini M, Sedona P (2008) Botulinum toxin type-A for the treatment of inverse psoriasis. J Eur Acad Dermatol Venereol JEADV 22(4):431–436. 10.1111/j.1468-3083.2007.02457.x
115. Ward NL, Kavlick KD, Diaconu D, Dawes SM, Michaels KA, Gilbert E (2012) Botulinum neurotoxin A decreases infiltrating cutaneous lymphocytes and improves acanthosis in the KC-Tie2 mouse model. J Investig Dermatol 132(7):1927–1930. 10.1038/jid.2012.60
116. Todberg T, Zachariae C, Bregnhoj A, Hedelund L, Bonefeld KK, Nielsen K, Iversen L, Skov L (2017) The effect of botulinum neurotoxin A in patients with plaque psoriasis—an exploratory trial. J Eur Acad Dermatol Venereol JEADV 32:e81–e82. 10.1111/jdv.14536
117. Leung DY, Bieber T (2003) Atopic dermatitis. Lancet (London, England) 361(9352):151–160. 10.1016/s0140-6736(03)12193-9
118. Tominaga M, Tengara S, Kamo A, Ogawa H, Takamori K (2009) Psoralen-ultraviolet A therapy alters epidermal Sema3A and NGF levels and modulates epidermal innervation in atopic dermatitis. J Dermatol Sci 55(1):40–46. 10.1016/j.jdermsci.2009.03.007
119. Dou YC, Hagstromer L, Emtestam L, Johansson O (2006) Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical study. Arch Dermatol Res 298(1):31–37. 10.1007/s00403-006-0657-1
120. Jarvikallio A, Harvima IT, Naukkarinen A (2003) Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema. Arch Dermatol Res 295(1):2–7. 10.1007/s00403-002-0378-z
121. Tobin D, Nabarro G, Baart de la Faille H, van Vloten WA, van der Putte SC, Schuurman HJ (1992) Increased number of immunoreactive nerve fibers in atopic dermatitis. J Allergy Clin Immunol 90(4 Pt 1):613–622
122. Ostlere LS, Cowen T, Rustin MH (1995) Neuropeptides in the skin of patients with atopic dermatitis. Clin Exp Dermatol 20(6):462–467
123. Roggenkamp D, Falkner S, Stab F, Petersen M, Schmelz M, Neufang G (2012) Atopic keratinocytes induce increased neurite outgrowth in a coculture model of porcine dorsal root ganglia neurons and human skin cells. J Investig Dermatol 132(7):1892–1900. 10.1038/jid.2012.44
124. Yamaguchi J, Aihara M, Kobayashi Y, Kambara T, Ikezawa Z (2009) Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis. J Dermatol Sci 53(1):48–54. 10.1016/j.jdermsci.2008.08.011
125. Takano N, Sakurai T, Ohashi Y, Kurachi M (2007) Effects of high-affinity nerve growth factor receptor inhibitors on symptoms in the NC/Nga mouse atopic dermatitis model. Br J Dermatol 156(2):241–246. 10.1111/j.1365-2133.2006.07636.x
126. Grewe M, Vogelsang K, Ruzicka T, Stege H, Krutmann J (2000) Neurotrophin-4 production by human epidermal keratinocytes: increased expression in atopic dermatitis. J Investig Dermatol 114(6):1108–1112. 10.1046/j.1523-1747.2000.00974.x
127. Tominaga M, Ogawa H, Takamori K (2008) Decreased production of semaphorin 3A in the lesional skin of atopic dermatitis. Br J Dermatol 158(4):842–844. 10.1111/j.1365-2133.2007.08410.x
128. Kinkelin I, Motzing S, Koltenzenburg M, Brocker EB (2000) Increase in NGF content and nerve fiber sprouting in human allergic contact eczema. Cell Tissue Res 302(1):31–37
129. Salomon J, Baran E (2008) The role of selected neuropeptides in pathogenesis of atopic dermatitis. J Eur Acad Dermatol Venereol JEADV 22(2):223–228. 10.1111/j.1468-3083.2007.02399.x
130. Kim KH, Park KC, Chung JH, Choi HR (2003) The effect of substance P on peripheral blood mononuclear cells in patients with atopic dermatitis. J Dermatol Sci 32(2):115–124
131. Gordon DJ, Ostlere LS, Holden CA (1997) Neuropeptide modulation of Th1 and Th2 cytokines in peripheral blood mononuclear leucocytes in atopic dermatitis and non-atopic controls. Br J Dermatol 137(6):921–927
132. Antunez C, Torres MJ, Lopez S, Rodriguez-Pena R, Blanca M, Mayorga C, Santamaria-Babi LF (2009) Calcitonin gene-related peptide modulates interleukin-13 in circulating cutaneous lymphocyte-associated antigen-positive T cells in patients with atopic dermatitis. Br J Dermatol 161(3):547–553. 10.1111/j.1365-2133.2009.09318.x
133. Pavlovic S, Daniltchenko M, Tobin DJ, Hagen E, Hunt SP, Klapp BF, Arck PC, Peters EM (2008) Further exploring the brain-skin connection: stress worsens dermatitis via substance P-dependent neurogenic inflammation in mice. J Investig Dermatol 128(2):434–446. 10.1038/sj.jid.5701079
134. Scholzen T, Armstrong CA, Bunnett NW, Luger TA, Olerud JE, Ansel JC (1998) Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol 7(2–3):81–96
135. Andoh T, Nagasawa T, Satoh M, Kuraishi Y (1998) Substance P induction of itch-associated response mediated by cutaneous NK1 tachykinin receptors in mice. J Pharmacol Exp Ther 286(3):1140–1145
136. Ohmura T, Hayashi T, Satoh Y, Konomi A, Jung B, Satoh H (2004) Involvement of substance P in scratching behaviour in an atopic dermatitis model. Eur J Pharmacol 491(2–3):191–194. 10.1016/j.ejphar.2004.03.047
137. Dando TM, Perry CM (2004) Aprepitant: a review of its use in the prevention of chemotherapy-induced nausea and vomiting. Drugs 64(7):777–794
138. Duval A, Dubertret L (2009) Aprepitant as an antipruritic agent? N Engl J Med 361(14):1415–1416. 10.1056/NEJMc0906670
139. Lee JH, Cho SH (2011) Korean red ginseng extract ameliorates skin lesions in NC/Nga mice: an atopic dermatitis model. J Ethnopharmacol 133(2):810–817. 10.1016/j.jep.2010.11.020
140. Liu B, Escalera J, Balakrishna S, Fan L, Caceres AI, Robinson E, Sui A, McKay MC, McAlexander MA, Herrick CA, Jordt SE (2013) TRPA1 controls inflammation and pruritogen responses in allergic contact dermatitis. FASEB J 27(9):3549–3563. 10.1096/fj.13-229948
141. Doyle JA, Connolly SM, Hunziker N, Winkelmann RK (1979) Prurigo nodularis: a reappraisal of the clinical and histologic features. J Cutan Pathol 6(5):392–403
142. Cowan MA (1964) Neurohistological changes in prurigo nodularis. Arch Dermatol 89:754–758
143. Johansson O, Liang Y, Emtestam L (2002) Increased nerve growth factor- and tyrosine kinase A-like immunoreactivities in prurigo nodularis skin—an exploration of the cause of neurohyperplasia. Arch Dermatol Res 293(12):614–619. 10.1007/s00403-001-0285-8
144. Liang Y, Jacobi HH, Reimert CM, Haak-Frendscho M, Marcusson JA, Johansson O (2000) CGRP-immunoreactive nerves in prurigo nodularis—an exploration of neurogenic inflammation. J Cutan Pathol 27(7):359–366
145. Mascarenhas NL, Wang Z, Chang YL, Di Nardo A (2017) TRPV4 mediates mast cell activation in cathelicidin-induced rosacea inflammation. J Investig Dermatol 137(4):972–975. 10.1016/j.jid.2016.10.046
146. Williams MR, Gallo RL (2017) Evidence that human skin microbiome dysbiosis promotes atopic dermatitis. J Investig Dermatol 137(12):2460–2461. 10.1016/j.jid.2017.09.010
147. Wang Z, Mascarenhas N, Eckmann L, Miyamoto Y, Sun X, Kawakami T, Di Nardo A (2017) Skin microbiome promotes mast cell maturation by triggering stem cell factor production in keratinocytes. J Allergy Clin Immunol 139(4):1205–1216 e1206. 10.1016/j.jaci.2016.09.019
148. Igawa S, Di Nardo A (2017) Skin microbiome and mast cells. Transl Res 184(6):68–76